| Шығарылым |
Атауы |
Файл |
| Том 14, № 2 (2022) |
Renal dysfunction in patients with acute pulmonary embolism: how to improve prognosis and management tactics? |
|
|
Klimkin P., Mikhailova Z., Ekimovskih A., Fukina N., Dementieva T.
|
| № 4 (2017) |
Impaired renal function in patients with degenerative distrophic diseases of the spine and axial spondyloarthritis receiving non-steroidal anti-inflammatory drugs |
|
|
Bichurina D., Gaydukova I., Aparkina A., Khondkaryan E., Rebrov A.
|
| № 1 (2013) |
Violations of the nutritivny status and low-protein diet with keto-analogues of essential amino-acids in prevention of protein and energy deficiency in patients with chronic kidney disease |
|
|
Milovanov Y., Aleksandrova I., Dobrosmyslov I.
|
| № 2 (2012) |
Malnutrition in haemodialysis treatment of acute and chronic kidney disease (practice guidelines) |
|
|
Milovanov Y., Aleksandrova I., Milovanova L., Dobrosmyslov I., Milovanov Y., Alexandrova I., Milovanova L., Dobrosmislov I.
|
| Том 14, № 2 (2022) |
Nutritional disorders among elderly and senile patients depending on the state of renal function |
|
|
Borkhanova E., Maksudova A., Alaskari S., Derbali M., Konyukhov E.
|
| № 1 (2011) |
Disturbances of calcium-phosphate metabolism disturbances in chronic kidney disease stage III - V |
|
|
Milovanova L., Milovanov Y., Kozlovskaya L.
|
| Том 14, № 3 (2022) |
Impaired sleep-wakefulness and quality of life in patients with arterial hypertension and chronic kidney disease |
|
|
Osipov E., Batyushin M., Nalgieva Z.
|
| № 2 (2013) |
Natriuretic peptides: diagnostic and prognostic significance in chronic kidney disease |
|
|
Rudenko T., Kutyrina I., Vasylieva M.
|
| № 4 (2018) |
Scientific worldview of Academician S.R. Mirotvortseva (1878-1949) (on the 140th |
|
|
Morgoshiya T.
|
| Том 14, № 3 (2022) |
The scientific legacy of professor g.a. zakharin (1829-1897) - A GREAT CLINICIAN AND TEACHER. on the 125th anniversary of the scientist's death |
|
|
Morgoshiya T., Inkin A.
|
| Том 14, № 3 (2022) |
Non-diabetic glucosuria in patients with primary chronic pyelonephritis |
|
|
Berdichevsky V., Zhmurov V., Romanova A., Rasulov F., Khilkevich S., Boldyrev A., Gonyaev A., Bichenova A.
|
| Том 14, № 1 (2022) |
Essential amino acids and their α-ketoand hydroxy analogues in the diet of uremic patients (biochemical aspect) |
|
|
Malinovsky A.
|
| № 4 (2010) |
NEFRINURIYa KAK POKAZATEL' STRUKTURNO-FUNKTsIONAL'NYKh NARUShENIY GLOMERULYaRNOGO FIL'TRA U BOL'NYKh PROTEINURIChESKIMI FORMAMI NEFRITA |
|
|
Chebotareva N., N Bobkova I., Kozlovskaya L.
|
| Том 16, № 1 (2024) |
Nephrogenic anemia in patients receiving renal replacement therapy, pathogenesis and resistance |
|
|
Ryasnyansky V., Shostka G., Anikonova L.
|
| № 6 (2010) |
Nephrogenic anemia: influence on cardiovascular prognosis and chronic kidney disease progression |
|
|
Milovanov Y., Milovanova L., Kozlovskaya L.
|
| № 3 (2013) |
Nephrocardioprotective role of the Klotho protein circulating form in patients with chronic kidney disease |
|
|
Milovanova L., Milovanov Y., Kozlovskaya L.
|
| № 3 (2014) |
Nephrolithyasis a sign of idopathic hypercalciuria in children -inhabitants of Barnaul City |
|
|
Mikheeva N., Zverev Y., Vyhodtseva G., Lobanov Y.
|
| № 3-4 (2016) |
Nephrolithiasis of transplanted kidney |
|
|
Yankovoy A., Ivanov A., Urenkov S.
|
| Том 15, № 3 (2023) |
Nephrological service of the Russian Federation 2022: post-covid period. Clinical nephrology |
|
|
Shilov E., Shilova M., Rumyantseva E., Batyushin M., Bevzenko A., Belskikh A., Veselkova N., Yesayan A., Ivliev S., Kotenko O., Petrova N., Statsenko M., Stolyar A.
|
| Том 16, № 1 (2024) |
Nephrological service of the Russian Federation 2023: Part I. Renal Replacement Therapy |
|
|
Shilov E., Shilova M., Rumyantseva E., Batyushin M., Bevzenko A., Belskikh A., Veselkova N., Yesayan A., Ivliev S., Kotenko O., Petrova N., Statsenko M., Stolyar A.
|
| Том 16, № 4 (2024) |
Nephrological service of the Russian Federation 2023: Part II. Resources and staff |
|
|
Shilov E., Shilova M., Rumyantseva E., Batyushin M., Bevzenko A., Belskikh A., Veselkova N., Yesayan A., Ivliev S., Kotenko O., Petrova N., Statsenko M., Stolyar A.
|
| Том 17, № 1 (2025) |
Nephrology service of the Russian Federation 2024: Part I. Renal replacement therapy |
|
|
Shilov E., Shilova M., Rumyantseva E., Batyushin M., Bevzenko A., Belskikh A., Veselkova N., Yesayan A., Ivliev S., Kotenko O., Petrova N., Statsenko M., Stolyar A.
|
| Том 12, № 4 (2020) |
Nephrological service of the Russian Federation in 2019-2020: report of the presidium of the specialized commission on nephrology of the expert council of the ministry of health of the Russian Federation |
|
|
Shilov E., Kotenko O., Shilova M., Milchakov K., Rumyantseva E., Khalfin R.
|
| № 4 (2011) |
Nephropathic cystinosis. An underestimated problem in pediatric nephrology |
|
|
Tsygin A., Kagan M., Kartamysheva N., Karagulyan N., Levchenko E.
|
| № 2 (2011) |
NEPHROPATHY IN HEROIN AND COCAINE ABUSERS |
|
|
- -.
|
| Том 12, № 4 (2020) |
Nephroprotective effects of sodium-glucose linked transporter-2 inhibitors |
|
|
Daminov B., Abdullaev S., Sharapov O.
|
| № 5 (2010) |
nephrotic crise |
|
|
- -.
|
| № 5 (2011) |
nephrotic syndrome in children |
|
|
- -.
|
| № 1 (2013) |
Nephrotic syndrome: diagnosis and treatment |
|
|
Skvortsov V., Tumarenko A., Skvortsova E., Ellenberger N.
|
| № 3 (2010) |
Low birth weight as a risk factor for chronic kidney disease |
|
|
- -.
|
| № 1 (2011) |
Low molecular weight heparins in nephrologists practice |
|
|
- -.
|
| № 3 (2014) |
Low molecular glycozaminoglycans prevention placental insufficiency in women with gestational hypertension |
|
|
Fedorenko A.
|
| № 1 (2018) |
Nikolay Alekseevich Mukhin |
|
|
- -.
|
| № 4 (2011) |
NO-PRODUCING FUNCTION OF KIDNEYS IN CHILDREN WITH CHRONIC PYELONEPHRITIS AND ARTERIAL HYPERTENSION |
|
|
Luchaninova V., Agapov E., Pogodaeva T.
|
| Том 12, № 2 (2020) |
New coronavirus infection COVID-19 in a patient after kidney allotransplantation |
|
|
Frolova N., Usatyuk S., Artyukhina L., Kotenko O., Mayorov V., Lysenko M.
|
| № 1 (2013) |
New approaches in treatment of gout: febuxostat |
|
|
Tseltsov V., Martynov A., Guschina Y., Illarionova T., Koroviakova E.
|
| Том 11, № 3 (2019) |
New instrumental options for optimizing the hemodialysis program |
|
|
Shilo V., Drachev Ivan Y.
|
| Том 17, № 3 (2025) |
New biomarkers of kidney diseases: a breakthrough in early and accurate diagnostics |
|
|
Aitbaev K., Murkamilov I., Fomin V., Murkamilova Z., Raimzhanov Z., Yusupov F., Yusupov A., Yusupova T., Yusupova Z., Baitelieva A.
|
| № 5 (2011) |
New opportunities in treatment of secondary hyperparathyreoidism in patients on program haemodialysis with combination of cinacalcet and low doses of low doses of vitamin D sterols |
|
|
Shutov E., Lashutin S., Lyuosev V., Ryabinskaya G., Gorelova E., Levankovskaya E.
|
| № 4 (2014) |
New opportunities of donor organ conservation in renal transplantation |
|
|
Stepanov V., Korshunov K., Yankovoy A.
|
| № 3-4 (2016) |
New iron-containing phosphate-binding agents for the correction of hyperphosphatemia in patients with chronic kidney disease |
|
|
Ermolenko V., Filatova N.
|
| № 4 (2017) |
New approaches in the diagnosis and treatment of CKD-MBD (KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) |
|
|
Batyushin M.
|
| № 3-4 (2016) |
New approaches to the correction of malnutrition in patients receiving chronic hemodialysis treatment |
|
|
Yakovenko A., Rumyantsev A., Esayan A.
|
| № 1 (2013) |
New trends in diagnosis and treatment of pathozoospermia after surgical treatment of varicocele |
|
|
Glybochko P., Alyaev Y., Chaly M., Usachyov O.
|
| № 5 (2014) |
Nocturia as a topical interdisciplinary problem of integrative medicine in xxi century: epidemiology and association with age-related comorbidity |
|
|
Tyuzikov I., Kalinchenko S., Vorslov L., Tishova Y., Grekov E.
|
| № 5 (2011) |
NSAID-induced nephropathies |
|
|
- -.
|
| Том 14, № 3 (2022) |
On the importance of continuity of scientific heritage in medicine in general and in nephrology in particular |
|
|
Bratchikov O., Zhilyaeva Y., Maksimov V.
|
| Том 12, № 3 (2020) |
O RABOTE PREZIDIUMA PROFIL'NOY KOMISSII |
|
|
Shilov E.
|
| № 1 (2018) |
Updated National Inventory of Medicines for 2018 |
|
|
- -.
|
| № 4 (2018) |
The apartness of HELLP-syndrome from preeclampsia: features of damage of kidney and other organs |
|
|
Kirsanova T., Vinogradova M., Kolyvanova A.
|
| № 5-6 (2015) |
Health schools for patients: physicians’ perspective |
|
|
Mamedova E., Batjushin M., Bykovskaja T.
|
| № 1 (2018) |
Simultaneous use of two peritoneal catheters for adequate peritoneal perfusion |
|
|
Yankovoy A., Smolyakov A.
|
| № 1 (2017) |
Obesity and kidney disease: hidden consequences of the epidemic |
|
|
Kovesdy C., Furth S., Zoccali C.
|
| № 3 (2010) |
Obesity as a factor of vascular remodeling |
|
|
Rudenko T., Kutyrina I., Rudenko T., Kutyrina I.
|
| № 5 (2014) |
Definition of heat shock proteins in the urine, serum and kidney tissue: significance for the assessment of activity and prognosis of chronic glomerulonephritis |
|
|
Chebotareva N., Neprintseva N., Bobkova I., Kozlovskaya L., Varshavsky V.
|
| № 4 (2013) |
Urinary level of podocyte damage and self-defence markers in patients with chronic glomerulonephritis |
|
|
Tchebotareva N., Neprintseva N., Es’kova O., Bobkova I., Kozlovskaya L.
|
| № 2 (2009) |
Determination of circulating amyloid precursor protein in diagnosis and monitoring of disease progression in systemic amyloidosis |
|
|
Rameev V., Kozlovskaya L., Malinina E., Serova A., Kogarko I., Kogarko B., Lyubimova N., Rameev V., Kozlovskaya L., Malinina E., Serova A., Kogarko I., Kogarko B., Liubimova N.
|
| № 3 (2010) |
Monocyte chemoattractant protein-1 and transforming growth factor-beta1 urinary excretion as a marker of renal fibrosis in chronic glomerulonephritis |
|
|
Chebotareva N., N Bobkova I., Kozlovskaya L., Varshavskiy V., Golitsyna E., Tchebotareva N., Bobkova I., Kozlovskaya L., Varshavskii V., Golytsina E.
|
| № 5 (2011) |
Optimal target hemoglobin level in chronic kidney disease patients, treated with erythropoesis-stimulating agents: controversial questions |
|
|
Kozlovskaya L., Milovanov Y., Milovanova L.
|
| № 2 (2013) |
Interdisciplinary approach to diagnosis of diseases of solitary kidney in men |
|
|
Tiuzikov I., Ivanov A.
|
| № 3-4 (2016) |
Neoplastic disease of the transplanted kidney |
|
|
Yankovoy A., Prokopenko E., Sinyutin A., Stepanov V.
|
| № 1 (2016) |
Experience in using high-performance parallel DNA sequencing to characterize the molecular genetic features of kidney angiomyolipoma |
|
|
Kuznetsova E., Mosyakova K., Tanas A., Chaplygina M., Alekseeva E., Shpot' E., Anoshkin K., Zaletaev D., Vinarov A., Strel'nikov V.
|
| № 2 (2012) |
EXPERIENCE OF DARBEPORETIN ALFA USE IN MANAGEMENT OF ANAEMIA IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY |
|
|
Novosel'tsev I., Novosel'tseva N., Kuznetsova E., Mikhaylova Y., Novoseltsev I., Novoseltseva N., Kuznetsova E., Mihailova Y., Novoseltsev I., Novoseltseva N., Kuznetsova E., Mihailova Y.
|
| № 1 (2013) |
Use of continuous erythropoietin receptor activator in treatment of anemia in patients with predialysis chronic kidney disease |
|
|
Milovanova L., Milovanov Y., Kozlovskaya L.
|
| № 3 (2018) |
Experience of treatment of renal anemia in patients on hemodialysis using epoetin alfa (Eralfon). Evaluation of the efficacy of therapy and comparison with foreign practice |
|
|
Shutov E., Kotenko O., Pushkina A., Lashutin S., Elembaeva P.
|
| № 4 (2018) |
Experience of the use of iron oxyhydroxide complex for the treatment of hyperphosphatemia in patients with stage 5 diabetic chronic kidney disease at the stage of starting dialysis therapy |
|
|
Batyushin M., Kastanayan A.
|
| № 6 (2013) |
Use of lateral abdominal roentgenography by Kauppila method for estimation of prevalence and severity of calcinosis of abdominal aorta in patients on program hemodialysis |
|
|
Domashenko O., Kulakov A., Riasniaskiy V., Margaeva B.
|
| № 2 (2011) |
Use of trihydric iron preparations in treatment of anemia in patients with pre-dialysis renal failure |
|
|
Milovanov Y., Milovanova L., Kozlovskaya L.
|
| № 4 (2011) |
Use of cinacalcet in children with chronic kidney disease stage V |
|
|
Molchanova M., Petrosyan E., Pankratenko T., Zverev D., Rumyantsev A., Bykova L., Gracheva L.
|
| № 5 (2013) |
Use of Blemaren in patients with uretherolithiasis |
|
|
Kalinina S., Korenkov D., Melkonian A.
|
| Том 15, № 2 (2023) |
Experience with the use of eculizumab in the treatment of thrombotic microangiopathy in a patient with systemic lupus erythematosus |
|
|
Chuev N., Frolova N., Iskhakov R., Usatyuk S., Terentyeva N.
|
| № 4 (2017) |
Experience of successful eradication of hcv in a patient with cryoglobulinemic vasculitis |
|
|
Arisheva O., Dyakova E., Frolova N., Kotenko O.
|
| Том 13, № 2 (2021) |
Organization of renal replacement therapy in emergency medicine in the context of new Coronaviral infection |
|
|
Rey S., Vasina N., Berdnikov G., Marchenkova L., Kotenko O.
|
| Том 12, № 2 (2020) |
Organization of the Moscow City nephrology service during the pandemic of the new coronavirus infection COVID-19 |
|
|
Kotenko O., Vasina N., Vinogradov V.
|
| № 4 (2015) |
Organ-preserving surgery of tumor lesions in transplanted kidney |
|
|
Jankovoj A., Prokopenko E., Bazaev V., Vatazin A., Kazanceva I., Gurevich L., Urenkov S., Sinjutin A., Stepanov V.
|
| № 2 (2011) |
Structural remodeling of myocardium in patients with arterial hypertension, receiving chronic haemodyalisis |
|
|
Rtishcheva O., Kalev O.
|
| № 2 (2016) |
Features in managing patients with chronic kidney disease and type 2 diabetes: the need for a multidisciplinary approach |
|
|
Mihajlova N., Tishkina S.
|
| № 5 (2014) |
Features venous flow kidney in acute pancreatitis |
|
|
Vinnik Y., Repina E., Serova E., Makarkin A., Plehanova E.
|
| № 5-6 (2015) |
Characteristic features of intrarenal blood flow in patients with essential hypertension and preclinical hypertensive nephropathy |
|
|
Krutikov E., Chistjakova S., Cvetkov V.
|
| № 1 (2017) |
Features of chronic kidney disease diagnosis in patient chronic obstructive pulmonary disease |
|
|
Bolotova E., Dudnikova A., Yavlyanskaya V.
|
| № 2 (2015) |
Features of renal dysfunction in patients with chronic obstructive pulmonary disease |
|
|
Bolotova E., Dudnikova A.
|
| № 3-4 (2016) |
Features of intrarenal blood flow in patients with chronic obstructive pulmonary disease |
|
|
Bolotova E., Dudnikova A., Eremeeva L., Kartavenkov S.
|
| № 2 (2010) |
Controlled clinical trials in nephrology |
|
|
Mukhin N., Nadelyaeva I., Moukhin N., Nadelyaeva I.
|
| Том 12, № 4 (2020) |
Features of pathogenetic mechanisms of protein-energy wasting development in patients with chronic kidney disease stage 5D |
|
|
Kuzyarova A., Gasanov M., Batyushin M., Bogomolova K., Adamokova I.
|
| Том 15, № 2 (2023) |
Features of kidney damage in metabolic syndrome |
|
|
Vorotylov A., Mikhailova Z.
|
| № 1 (2018) |
Features of renal blood flow and dynamics of uric acid concentration in women with pregnancy complicated by preeclampsia |
|
|
Akhmedov F., Negmatullaeva M., Avakov V.
|
| № 2 (2017) |
Features of development and clinical picture of pulmonary hypertension in patients with chronic kidney disease |
|
|
Dzheyentaev K., Kaliyev R.
|
| № 1 (2019) |
Features of regional blood flow in patients with neurogenic dysfunction of urination on the background of connective tissue dysplasia |
|
|
Lobanov Y., Latyshev D., Tekutyeva N., Mikheeva N., Chicherina A.
|
| № 4 (2009) |
OSOBENNOSTI REOLOGIChESKIKh SVOYSTV KROVI U BOL'NYKh VOLChANOChNYM NEFRITOM |
|
|
Krasnova T., Sokolova I., Gafarova M., Shakhnasarov A., Georginova O., Bobkova I., Nikiforova N., Roschupkina S., Rykova S.
|
| Том 17, № 2 (2025) |
Features of screening and diagnosis of renal cell carcinoma in kidney transplant recipients |
|
|
Trushkin R., Isaev T., Sokolov A., Sokolov S., Andreev S., Ho T.
|
| Том 13, № 3 (2021) |
Peculiarities of vascular remodeling in patients with chronic kidney disease stage 5D: prognostic role of the intima-media thickness |
|
|
Kolomyitseva M., Gasanov M., Batyushin M., Manukyan O., Rudenko L.
|
| № 5 (2010) |
Peculiarities of IgA-nephropathy clinical course, associated with excess body mass weight |
|
|
Saginova E., Aksyutin A., Krasnova T., Fomin V., Mukhin N.
|
| Том 13, № 2 (2021) |
Features of the course of AA-amyloidosis in rheumatoid arthritis against the background of COVID-19 infection |
|
|
Voloshinova E., Nikitina N., Smirnova N., Egorova E.
|
| № 6 (2010) |
Hypertensive nephropathy evolution in patients with metabolic syndrome |
|
|
Galushkin A., Batyushin M., Terent'ev V., Gorblyanskiy Y., Stepkova V., Volikov N.
|
| № 3 (2012) |
OSOBENNOSTI TEChENIYa I ISKhODA ATIPIChNOGO GEMOLITIKO-UREMIChESKOGO SINDROMA PRI BEREMENNOSTI |
|
|
Kozlovskaya N., Merkusheva L., Kirsanova T., Runikhina N.
|
| Том 16, № 1 (2024) |
Features of the course and the prognosis in patients with multiple myeloma depending on the renal involvement |
|
|
Grigoryan Z., Marchenko Y., Khachatryan M.
|
| № 4 (2010) |
OSOBENNOSTI TEChENIYa INFEKTsIONNOGO ENDOKARDITA U PATsIENTOV, NAKhODYaShchIKhSYa NA PROGRAMMNOM GEMODIALIZE |
|
|
Ponomareva E., Grigor'eva E., Tyapkina M.
|
| № 5 (2014) |
Features of acute kidney injury and chronic kidney disease in the elderly |
|
|
Nikolaev A., Ermolenko V.
|
| Том 16, № 2 (2024) |
Features of the course of chronic kidney disease and left ventricle geometry in women and men at the pre-dialysis stage of the disease |
|
|
Murkamilov I., Aitbaev K., Fomin V., Yusupova T., Duysheeva G., Yusupov F.
|
| № 2 (2012) |
Characteristics of renal tubule-interstitial dysfunction in patients with rheumatoid arthritis |
|
|
Rebrov A., Tyapkina M., Voloshinova E., Rebrov A., Tiapkina M., Voloshinova E., Rebrov A., Tiapkina M., Voloshinova E.
|
| Нәтижелер 951 - 401/500 |
<< < 1 2 3 4 5 6 7 8 9 10 > >> |
